Enhancing Oncology investigation with Integrated KRAS Assay products and services and RAS Assays
In the promptly evolving field of oncology research, accurate and successful mutation screening is essential for creating focused therapies. The KRAS companies System plays a pivotal function During this landscape by providing comprehensive answers for KRAS mutation profiling and Investigation. KRAS mutations, located in approximately ninety five%